Rankings
▼
Calendar
SCLX Q1 2025 Earnings — Scilex Holding Company Revenue & Financial Results | Market Cap Arena
SCLX
Scilex Holding Company
$73M
Q1 2025 Earnings
Healthcare
Drug Manufacturers - General
Income Statement
Revenue
$5M
-54.0% YoY
Gross Profit
$4M
72.3% margin
Operating Income
-$28M
-557.5% margin
Net Income
-$26M
-521.2% margin
EPS (Diluted)
$-2.26
QoQ Revenue Growth
-66.4%
Cash Flow
Operating Cash Flow
$6M
Free Cash Flow
$6M
Stock-Based Comp.
$3M
Balance Sheet
Total Assets
$79M
Total Liabilities
$290M
Stockholders' Equity
-$211M
Cash & Equivalents
$6M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$5M
$11M
-54.0%
Gross Profit
$4M
$7M
-48.6%
Operating Income
-$28M
-$19M
-43.2%
Net Income
-$26M
-$24M
-7.0%
← Q4 2024
All Quarters
Q2 2025 →